1-9 of 9
Gerald J. Gleich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera

Ami B. Patel, Anca Franzini, Emilie Leroy, Soo Jin Kim, Anthony D. Pomicter, Lidvine Genet, Michael Xiao, Dongqing Yan, Jonathan M. Ahmann, Archana M. Agarwal, Phillip Clair, Juanah Addada, Jonathan Lambert, Matthew Salmon, Gerald J. Gleich, Nicholas C. P. Cross, Stefan N. Constantinescu, Thomas O’Hare, Josef T. Prchal, Michael W. Deininger
Journal: Blood
Blood (2019) 134 (26): 2388–2398.
https://doi.org/10.1182/blood.2019001385
Published: 2019
Includes: Supplemental data
Journal Articles

Dexpramipexole: a new antieosinophil drug?

Clinical Trials & Observations
Gerald J. Gleich
Journal: Blood
Blood (2018) 132 (5): 461–462.
https://doi.org/10.1182/blood-2018-06-851600
Published: 2018
Journal Articles

EGO , a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression

Lori A. Wagner, Clarissa J. Christensen, Diane M. Dunn, Gerald J. Spangrude, Ann Georgelas, Linda Kelley, M. Sean Esplin, Robert B. Weiss, Gerald J. Gleich
Journal: Blood
Blood (2007) 109 (12): 5191–5198.
https://doi.org/10.1182/blood-2006-06-027987
Published: 2007
Includes: Supplemental data
Journal Articles

Steroid-Sparing Effects of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Marc E. Rothenberg, MD, PhD, Gerald J. Gleich, MD, Florence E. Roufosse, MD, Lanny J. Rosenwasser, MD, Peter F. Weller, MD
Journal: Blood
Blood (2006) 108 (11): 373.
https://doi.org/10.1182/blood.V108.11.373.373
Published: 2006
Journal Articles

Baseline Demographics and Disease Characteristics of Patients with Hypereosinophilic Syndrome in a Placebo-Controlled Trial Evaluating the Steroid-Sparing Effects of the Anti-IL-5 Monoclonal Antibody, Mepolizumab.

Gerald J. Gleich, MD, Lawrence B. Schwartz, MD PhD, William W. Busse, MD, Johannes Huss-Marp, MD, Scott R. Walsh, MD PhD
Journal: Blood
Blood (2006) 108 (11): 4899.
https://doi.org/10.1182/blood.V108.11.4899.4899
Published: 2006
Journal Articles

Non-IgE–dependent activation of human lung– and cord blood–derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor

Adrian M. Piliponsky, Gerald J. Gleich, Arnon Nagler, Ilan Bar, Francesca Levi-Schaffer
Journal: Blood
Blood (2003) 101 (5): 1898–1904.
https://doi.org/10.1182/blood-2002-05-1488
Published: 2003
Journal Articles

Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli

Hitoshi Kobayashi, Gerald J. Gleich, Joseph H. Butterfield, Hirohito Kita
Journal: Blood
Blood (2002) 99 (6): 2214–2220.
https://doi.org/10.1182/blood.V99.6.2214
Published: 2002
Journal Articles

Regulation and Processing of a Precursor Form of Eosinophil Granule Major Basic Protein (ProMBP) in Differentiating Eosinophils

Pamela Popken-Harris, James Checkel, David Loegering, Benjamin Madden, Margaret Springett, Gail Kephart, Gerald J. Gleich
Journal: Blood
Blood (1998) 92 (2): 623–631.
https://doi.org/10.1182/blood.V92.2.623
Published: 1998
Journal Articles

Eosinophils and IgE Receptors: A Continuing Controversy

Hirohito Kita, Gerald J. Gleich
Journal: Blood
Blood (1997) 89 (10): 3497–3501.
https://doi.org/10.1182/blood.V89.10.3497
Published: 1997